MktsMarkets

Tarsus Pharmaceuticals, Inc.
NASDAQ: TARSKey statistics
TARS News
Stories mentioning TARS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 162,054 | 151,668 | 118,697 | 102,660 | 78,335 | 66,408 | 48,118 | 40,813 |
| Cost of Goods Sold | 9,396 | 5,211 | ||||||
| Gross Profit | 152,658 | 73,124 | ||||||
| Operating Expenses | ||||||||
| Research & Development | 22,351 | 18,035 | 16,284 | 15,594 | 14,409 | 16,873 | 12,128 | 12,319 |
| Sales General & Admin | 136,429 | 130,682 | 108,633 | 103,013 | 84,995 | 69,030 | 57,910 | 58,792 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (6,122) | (7,976) | (14,529) | (22,184) | (26,280) | (24,421) | (25,162) | (33,302) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (87.00) | (74.00) | 98.00 | (145.00) | (81.00) | (27.00) | 67.00 | (65.00) |
| Pretax Income | ||||||||
| Tax Provision | 2,352 | 0.00 | ||||||
| Net Income (Loss) | (6,967) | (8,373) | (12,585) | (20,340) | (25,120) | (23,113) | (23,420) | (33,290) |
| Earnings Per Share (Basic) | (0.16) | (0.20) | (0.30) | (0.48) | (0.64) | (0.61) | (0.61) | (0.88) |
| Earnings Per Share (Diluted) | (0.16) | (0.20) | (0.30) | (0.48) | (0.64) | (0.61) | (0.61) | (0.88) |
| Weighted Average Shares Outstanding (Basic) | 42,957 | 41,784 | 42,608 | 42,360 | 39,345 | 37,605 | 38,382 | 37,823 |
| Weighted Average Shares Outstanding (Diluted) | 42,957 | 41,784 | 42,608 | 42,360 | 39,345 | 37,605 | 38,382 | 37,823 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TARS
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is a stock listed on the Nasdaq Stock Market under the ticker symbol TARS. It last traded at $73.01 (Nov 20, 2026, 4:00 PM ET), down 6.0% on the day. That gives Tarsus Pharmaceuticals a market capitalisation of $3.6B.
Over the past 52 weeks TARS has traded between $53.89 and $91.53.
Revenue for the quarter ended Mar 31, 2026 was $162.1M; a net loss of $7.0M. Revenue was up 107% from $78.3M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $162.1M | -$7.0M | -4.3% |
| Dec 31, 2025 | $151.7M | -$8.4M | -5.5% |
| Sep 30, 2025 | $118.7M | -$12.6M | -10.6% |
| Jun 30, 2025 | $102.7M | -$20.3M | -19.8% |
From Tarsus Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…